Aastrom Biosciences, Inc. (ASTM) Reports Third-Quarter and Nine-Month 2013 Financial Results
11/13/2013 9:40:32 AM
ANN ARBOR, Mich., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today reported financial results for the quarter and nine months ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by